Richard Lehman`s Journal Review – 23 February 2015: blog in the BMJ :
“Lancet 21 Feb 2015 Vol 385
“When mammographic screening for the early detection of breast cancer was introduced in the UK, its benefits were deliberately talked up to maximize uptake.”
“Many women will probably trust that an invitation from health authorities strongly indicates that the intervention is worthwhile” (editorial).
It also includes a link to an Australian trial by Jolyn Hersch et al on ‘Use of a decision aid including information on overdetection to support informed choice about breast screening’.This compared
the effect of using an information package which included information about the harms of overdiagnosis, with one that did not. “